SCHEMBL6196317

SCHEMBL6196317

Cc1cc(NC(=O)NCCN2CCC(NC(=O)c3cccc(Cl)c3)C2)c2ccccc2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UTS2R Q9UKP6 3/20 0.54
ADRA2A P08913 2/20 0.54
DRD2 P14416 2/20 0.54
SLC6A2 P23975 1/20 0.54
HTR2A P28223 1/20 0.54
HTR2C P28335 1/20 0.54
SLC6A4 P31645 1/20 0.54
TMEM97 Q5BJF2 1/20 0.54
SIGMAR1 Q99720 1/20 0.54
CACNA1H O95180 2/20 0.51
CYP2D6 P10635 2/20 0.51
KCNH2 Q12809 2/20 0.51
MCHR1 Q99705 2/20 0.47
HTR1A P08908 1/20 0.46
HTR7 P34969 1/20 0.46
CCR2 P41597 2/20 0.46
DRD4 P21917 2/20 0.45
IGF1R P08069 1/20 0.45
CARM1 Q86X55 1/20 0.43
PRMT6 Q96LA8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6198048 0.95 UTS2R (0.57) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6197401 0.93 UTS2R (0.59) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6196817 0.90 UTS2R (0.53) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6194976 0.90 UTS2R (0.56) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6199511 0.88 UTS2R (0.56) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6196741 0.87 UTS2R (0.64) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6195795 0.87 UTS2R (0.61) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6196924 0.87 UTS2R (0.54) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6199787 0.87 UTS2R (0.55) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6199808 0.86 UTS2R (0.55) UTS2RADRA2ADRD2SLC6A2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1499607-B1 4-(PIPERIDYL- AND PYRROLIDYL-ALKYL-UREIDO)-QUINOLINES AS UROTENSIN II RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2005-12-07 EP disclosed